Showing 87 results
Mouse model mimics AMD pathology, enabling preclinical testing of gene therapies targeting complement factor H and related inflammatory diseases.
Six diverse colorectal cancer cell lines enable research into tumour biology, differentiation, and integrin expression for drug development.
Transgenic mouse model mimics CMT1A pathology, enabling gene therapy testing for inherited neuropathies and autoimmune neurological disorders.
